Methods of using...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4375 (2006.01) A61P 35/00 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2620915

Methods of treating, preventing or managing cancer, including certain leukernias are disclosed. The methods encompass the administration of enantiomerically pure (+)-l,4- dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-l- pyrrolidinyl]-4-oxo-l-(2-thiazolyl)-l,8- naphthyridine-3-carboxylic acid. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.

L'invention porte sur des méthodes de traitement, prévention et gestion des cancers dont certaines leucémies consistant à administrer de l'acide (+)-1,4-dihydro-7-[(3s,4s)-3-méthoxy-4-(méthylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylique énantiomèrement pur et sur des méthodes de traitement utilisant ce composé en association avec la chimiothérapie, la radiothérapie, l'hormonothérapie, des thérapies biologiques ou l'immunothérapie. L'invention porte également sur des préparations pharmaceutiques et des formes posologiques unitaires utilisables dans lesdites méthodes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Methods of using... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of using..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of using... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1649729

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.